Literature DB >> 17410321

Interaction between estrogen receptor-alpha and butyrylcholinesterase genes modulates Alzheimer's disease risk.

Onofre Combarros, José Antonio Riancho, Jana Arozamena, Ignacio Mateo, Javier Llorca, Jon Infante, Pascual Sánchez-Juan, María Teresa Zarrabeitia, José Berciano.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17410321     DOI: 10.1007/s00415-006-0502-7

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  21 in total

1.  Positive association between an estrogen receptor gene polymorphism and Parkinson's disease with dementia.

Authors:  K Isoe-Wada; M Maeda; J Yong; Y Adachi; H Harada; K Urakami; K Nakashima
Journal:  Eur J Neurol       Date:  1999-07       Impact factor: 6.089

2.  DNA mutation associated with the human butyrylcholinesterase K-variant and its linkage to the atypical variant mutation and other polymorphic sites.

Authors:  C F Bartels; F S Jensen; O Lockridge; A F van der Spek; H M Rubinstein; T Lubrano; B N La Du
Journal:  Am J Hum Genet       Date:  1992-05       Impact factor: 11.025

3.  Lack of an association of estrogen receptor alpha gene polymorphisms and transcriptional activity with Alzheimer disease.

Authors:  H Maruyama; H Toji; C R Harrington; K Sasaki; Y Izumi; T Ohnuma; H Arai; M Yasuda; C Tanaka; P C Emson; S Nakamura; H Kawakami
Journal:  Arch Neurol       Date:  2000-02

4.  Are the estrogen receptors involved in Alzheimer's disease?

Authors:  J C Lambert; J M Harris; D Mann; H Lemmon; J Coates; A Cumming; D St-Clair; C Lendon
Journal:  Neurosci Lett       Date:  2001-06-29       Impact factor: 3.046

5.  Common estrogen receptor polymorphism augments effects of hormone replacement therapy on E-selectin but not C-reactive protein.

Authors:  David M Herrington; Timothy D Howard; K Bridget Brosnihan; Donald P McDonnell; Xiaolin Li; Gregory A Hawkins; David M Reboussin; Jianfeng Xu; Siqun L Zheng; Deborah A Meyers; Eugene R Bleecker
Journal:  Circulation       Date:  2002-04-23       Impact factor: 29.690

Review 6.  The cholinergic hypothesis of Alzheimer's disease: a review of progress.

Authors:  P T Francis; A M Palmer; M Snape; G K Wilcock
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-02       Impact factor: 10.154

7.  Polymorphism of alpha-estrogen receptor and aryl hydrocarbon receptor genes in dementia patients in Shanghai suburb.

Authors:  Guo-Fang Lin; Qing-Wen Ma; Dong-Sheng Zhang; Yong-Lin Zha; Ke-Jian Lou; Jian-Hua Shen
Journal:  Acta Pharmacol Sin       Date:  2003-07       Impact factor: 6.150

8.  No genetic association between the myeloperoxidase gene -463 polymorphism and estrogen receptor-alpha gene polymorphisms and Japanese sporadic Alzheimer's disease.

Authors:  Chie Usui; Nobuto Shibata; Tohru Ohnuma; Shinji Higashi; Taku Ohkubo; Akira Ueki; Masatsugu Nagao; Heii Arai
Journal:  Dement Geriatr Cogn Disord       Date:  2006-02-10       Impact factor: 2.959

Review 9.  The neuroprotective effects of estrogen on the aging brain.

Authors:  Ray Norbury; William J Cutter; Jacqueline Compton; Dene M Robertson; Michael Craig; Malcolm Whitehead; Declan G Murphy
Journal:  Exp Gerontol       Date:  2003 Jan-Feb       Impact factor: 4.032

10.  Association of the estrogen receptor alpha gene polymorphisms with sporadic Alzheimer's disease.

Authors:  M L Brandi; L Becherini; L Gennari; M Racchi; A Bianchetti; B Nacmias; S Sorbi; P Mecocci; U Senin; S Govoni
Journal:  Biochem Biophys Res Commun       Date:  1999-11-19       Impact factor: 3.575

View more
  2 in total

1.  BuChE K variant is decreased in Alzheimer's disease not in fronto-temporal dementia.

Authors:  Alessandra Bizzarro; V Guglielmi; R Lomastro; A Valenza; A Lauria; C Marra; M C Silveri; F D Tiziano; C Brahe; C Masullo
Journal:  J Neural Transm (Vienna)       Date:  2010-03       Impact factor: 3.575

2.  Genetic Factors Affecting Late-Onset Alzheimer's Disease Susceptibility.

Authors:  Maryam Rezazadeh; Aziz Khorrami; Tarlan Yeghaneh; Mahnaz Talebi; Seyed Jalal Kiani; Yaser Heshmati; Jalal Gharesouran
Journal:  Neuromolecular Med       Date:  2015-11-09       Impact factor: 3.843

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.